Advanced Search
DSpace@MIT

The role of heparan sulfate proteoglycans and heparanase in the control of vascular remodeling

Research and Teaching Output of the MIT Community

Show simple item record

dc.contributor.advisor Elazer R. Edelman. en_US
dc.contributor.author Baker, Aaron Blair en_US
dc.contributor.other Harvard University--MIT Division of Health Sciences and Technology. en_US
dc.date.accessioned 2007-02-21T11:48:58Z
dc.date.available 2007-02-21T11:48:58Z
dc.date.copyright 2006 en_US
dc.date.issued 2006 en_US
dc.identifier.uri http://hdl.handle.net/1721.1/36164
dc.description Thesis (Ph. D.)--Harvard-MIT Division of Health Sciences and Technology, 2006. en_US
dc.description Includes bibliographical references (p. 136-148). en_US
dc.description.abstract Arterial remodeling is a major pathophysiological mechanism underlying clinical cardiovascular disorders such as hypertension, atherosclerosis and restenosis. We examined heparan sulfate proteoglycan homeostasis as a mechanism of regulation of arterial vascular remodeling in response to altered mechanical environments such as hypertension and injury. We first studied the effect of in-vitro mechanical strain on the ability of endothelial cells to inhibit vascular smooth muscle cell proliferation. Under these conditions we found mechanical strain increased endothelial inhibition of smooth muscle cell proliferation through increased production of heparan sulfate proteoglycans. Using inhibitors to p38 MAPK and ERK, we showed that activation of both of these pathways was essential for load-induced heparan sulfate production, TGF-,f1 activation, smad-2 activation and increased FGF-2 uptake. Further, we exposed cells to strain in the presence of a neutralizing antibody to TGF-P 1 and demonstrated that autocrine TGF-1l signaling was essential for load-induced HSPG production and sustained p38 MAPK and ERK activation. en_US
dc.description.abstract (cont.) We also examined the endothelium of spontaneously hypertensive rats using immunohistochemical staining for heparan sulfate proteoglycan core proteins, TGF-31 and phosphorylated signaling intermediates and found results that correlated well with our in-vitro experiments. Taken together these results imply a novel paradigm of vascular remodeling to mechanical stimuli in which net arterial remodeling is controlled by the dynamic interplay between pro-growth signals from vascular smooth muscle cells and anti-growth signals from endothelial cells. In a second portion of this work, we examined the role of heparanase in vascular remodeling. Using siRNA gene silencing and overexpression techniques, we showed that alterations in heparanase expression lead to a profound modulation in endothelial inhibition of vascular smooth muscle cell proliferation. In vivo, we quantified heparanase expression in animal models of hypertension, vascular disease and injury. Immunohistochemical analysis of the aortae of hypertensive rats revealed an increase in endothelial production of heparanase that strongly correlated with increased aortic structural remodeling. en_US
dc.description.abstract (cont.) Studies of vascular injury with stenting in the Zucker rat model of diabetes showed a relationship between neointimal heparanase expression and lesion thickness. Our results define a new role for heparanase as a key molecular controller of vascular remodeling in diverse disease states. en_US
dc.description.statementofresponsibility by Aaron B. Blair. en_US
dc.format.extent 148 leaves en_US
dc.language.iso eng en_US
dc.publisher Massachusetts Institute of Technology en_US
dc.rights M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. en_US
dc.rights.uri http://dspace.mit.edu/handle/1721.1/7582
dc.subject Harvard University--MIT Division of Health Sciences and Technology. en_US
dc.title The role of heparan sulfate proteoglycans and heparanase in the control of vascular remodeling en_US
dc.type Thesis en_US
dc.description.degree Ph.D. en_US
dc.contributor.department Harvard University--MIT Division of Health Sciences and Technology. en_US
dc.identifier.oclc 73722841 en_US


Files in this item

Name Size Format Description
73722841.pdf 26.61Mb PDF Preview, non-printable (open to all)
73722841-MIT.pdf 26.61Mb PDF Full printable version (MIT only)

This item appears in the following Collection(s)

Show simple item record

MIT-Mirage